AIDS Tricombination Therapies Subproject 1
AIDS Tricombination Therapies Subproject 1
批准号:
10616451
负责人:
CHARLES HEBERT
金额:
$70.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-23 至 2023-04-30
关键词:
AIDS therapyAIDS/HIV problemAcquired Immunodeficiency SyndromeAdultAdverse effectsAffectAnimalsBiological MarkersBirthBone DevelopmentChemicalsClinicalCommunitiesCongenital AbnormalityDevelopmentDoseDrug CombinationsDrug usageEnvironmental PollutionExhibitsExposure toFDA approvedFetal DevelopmentFetal WeightFlame RetardantsGenerationsGoalsHIV InfectionsHIV SeropositivityHazardous ChemicalsHealthHumanIndividualIndustrializationInfertilityInvestigationLaboratory AnimalsLaboratory RatLaboratory miceLifeMaterials TestingMedicalMonitorNational Toxicology ProgramOvaryPatientsPersonsPharmaceutical PreparationsPopulationPrimatesPubertyRattusRodentSafetyStavudineTenofovirTestisTherapeuticToxic effectToxicity TestsWeight GainWomanWorld Health OrganizationZidovudineadverse outcomecardiovascular effectscompliance behaviorcritical perioddesigndietary supplementsdisorder preventionearly life exposureefavirenzemtricitabinefetalin uteromedication safetyneurodevelopmentoffspringpersonal care productspostnatal developmentpregnantprenatal exposureprogramspublic health researchreproductive organreproductive toxicitytumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this project is to provide support of Division of the National Toxicology Program (DNTP) activities targeted toward the prevention of diseases or adverse effects caused by exposure to chemical or physical agents. Toxicity testing is an important aspect of public health research in that it serves to identify chemicals that are hazardous to human health. This program is designed to evaluate toxicity following early life exposure to chemicals.
For this project, laboratory rats and mice are exposed to various test materials during fetal development and exposures may continue after birth and through adulthood. Animals are evaluated for adverse effects at different stages of life for effects such as changes in onset of puberty, infertility or other reproductive toxicity such as adverse effects on reproductive organs including ovaries or testes, and development of tumors or other adverse outcomes. Examples of chemical classes studied include personal care product ingredients, flame retardants, dietary supplements, industrial chemicals, environmental contaminants and drugs including AIDS therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF Task Order #2 for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments"
-
批准号:10022440
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2019
-
负责人:CHARLES HEBERT
-
依托单位:
IGF::OT::IGF TASK ORDER #001 PERFORMANCE AREA 1 MANAGEMENT AND OPERATIONS SUPPORT
-
批准号:9785331
-
项目类别:
-
资助金额:$10.02万
-
财政年份:2017
-
负责人:CHARLES HEBERT
-
依托单位:
IGF::OT::IGF TASK ORDER #001 PERFORMANCE AREA 1 MANAGEMENT AND OPERATIONS SUPPORT
-
批准号:9376290
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2016
-
负责人:CHARLES HEBERT
-
依托单位:
IGF::OT::IGF CONTRACTOR ORIENTATION AND KICKOFF MEETING FOR SRI
-
批准号:9161865
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2015
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Subproject 4
-
批准号:10616454
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Subproject: Resveratrol Subproject 3
-
批准号:10616453
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Subproject 4
-
批准号:10833988
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Combination Therapy Subproject 2
-
批准号:10616452
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Resveratrol Subproject 2
-
批准号:10399955
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Tricombination Therapies Subproject 1
-
批准号:9915363
-
项目类别:
-
资助金额:$240.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Combination Therapy Subproject 2
-
批准号:10833986
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Tricombination Therapies Subproject 1
-
批准号:10833985
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
Support of the Research Effort to Evaluate Toxicity Following Early Life Exposure to Test Articles for the NTP
-
批准号:9315665
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
Other Projects, Deoxynivalenol Subproject 3
-
批准号:9915365
-
项目类别:
-
资助金额:$21.54万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Subproject: Resveratrol Subproject 3
-
批准号:10833987
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Tricombination Therapies Subproject 1
-
批准号:10399954
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Subproject: Resveratrol Subproject 3
-
批准号:10399956
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
IGF::OT::IGFSupport of the Research Effort to Evaluate Toxicity Following Early Life Exposure to Test Articles for the NTP
-
批准号:8947879
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
AIDS Resveratrol Subproject 2
-
批准号:9915364
-
项目类别:
-
资助金额:$154.9万
-
财政年份:2013
-
负责人:CHARLES HEBERT
-
依托单位:
Preclinical Pharmacology and Toxicology Studies
-
批准号:7891915
-
项目类别:
-
资助金额:$68.66万
-
财政年份:2004
-
负责人:CHARLES HEBERT
-
依托单位: